SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Charles Darwin — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientCharles Darwin
Date of birth1809-02-12
IdentifiersMRN HR-NI003-SYN-TD; SSN (made up) 000-03-2967
Document date1849-07-21
AuthorBernard Ashworth, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Preventive health visit; no new complaints. [S]

History of Present Illness

Mr. Darwin is a 40-year-old man with a provisional diagnosis of cyclic vomiting syndrome who comes for his preventive health visit, six weeks after his three-month review. He has had no vomiting episode since then and no emergency visits this year since starting treatment. He takes amitriptyline 75 mg at bedtime with a dry mouth and mild constipation, and carries his sumatriptan and ondansetron. His cold in May cleared in two weeks without an episode. He walks most days and practices relaxation breathing each evening. He completed the health risk assessment in the waiting room. [S]

ElementDetail
VisitPeriodic preventive visit, age 40
Active conditionsCyclic vomiting syndrome, provisional, on amitriptyline prophylaxis
MedicinesAmitriptyline 75 mg at bedtime; sumatriptan nasal spray and ondansetron dissolving tablets for episodes
Safety eventsNo emergency visits or hospital stays since treatment began

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthBetter than in the winter, in his words
PsychosocialLives with his family; works from home; less worried about episodes in company since treatment began
Tobacco and nicotineDoes not smoke or vape
AlcoholOne or two glasses of wine a week (AUDIT-C 2)
Cannabis and other drugsNone
Physical activityWalks 30 to 45 minutes most days
NutritionRegular small meals, as advised for his trigger plan
SleepSeven to eight hours; mild morning grogginess on amitriptyline
Home and road safetyWears a seat belt; smoke detectors working; no firearms in the home
Sexual healthOne long-term partner; no new partners
Hearing and visionNo concerns

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight up 1 kg since treatment began; no fever or night sweats
EyesNegativeNo blurred vision
Ears, nose, mouth, and throatPositiveDry mouth on amitriptyline; cold resolved
CardiovascularNegativeNo chest pain or fainting; palpitations only in past prodromes
RespiratoryNegativeNo cough or breathlessness
GastrointestinalPositiveMild constipation on amitriptyline; wind between episodes less troublesome; no vomiting since the three-month review
GenitourinaryNegativeNo hesitancy or urinary symptoms
MusculoskeletalNegativeNo joint pain
IntegumentaryNegativeNo rash or changing moles
NeurologicalNegativeNo headaches or dizziness
PsychiatricNegativeMood good; PHQ-2 score 0; no thoughts of self-harm
EndocrineNegativeNo heat or cold intolerance

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amitriptyline 25 mg oral tablet, one tablet at bedtimeOne tablet by mouth at bedtimeOral route1849-04-14 to 1849-04-28completedS
Amitriptyline 50 mg oral tablet, one tablet at bedtimeOne tablet by mouth at bedtimeOral route1849-04-28 to 1849-05-12completedS
Amitriptyline 75 mg oral tablet, one tablet at bedtimeOne tablet by mouth at bedtimeOral route1849-05-12activeS
Sumatriptan 20 mg nasal spray, one spray at the first sign of an episodeOne spray in one nostril at the start of the prodrome; may repeat once after 2 hours; no more than 2 sprays a day or 6 a weekNasal route1849-04-14activeS
Ondansetron 8 mg orally disintegrating tablet at the first sign of an episodeDissolve one tablet on the tongue at the start of the prodrome, then every 8 hours as needed during an episodeOral route1849-04-14activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1849-07-21Body height183cmS
1849-07-21Body weight72.6kgS
1849-07-21Body mass index (BMI) [Ratio]21.7kg/m2S
1849-07-21Systolic blood pressure116mm[Hg]S
1849-07-21Diastolic blood pressure72mm[Hg]S
1849-07-21Heart rate70/minS
1849-07-21Respiratory rate14/minS
1849-07-21Body temperature36.6CelS
1849-07-21Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1849-07-21Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1849-07-21Total score [AUDIT-C]2{score}S
1849-07-21Cholesterol [Mass/volume] in Serum or Plasma178mg/dL<=200 mg/dLNormalS
1849-07-21Cholesterol in HDL [Mass/volume] in Serum or Plasma58mg/dL>=40 mg/dLNormalS
1849-07-21Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation102mg/dL<=129 mg/dLNormalS
1849-07-21Triglyceride [Mass/volume] in Serum or Plasma90mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 1849-07-21; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell and relaxed; weight 72.6 kg, BMI 21.7
EyesPupils equal and reactive; visual acuity 20/20 both eyes
Ears, nose, and throatCanals and drums normal; oral mucosa slightly dry; dentition good
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm at 70 per minute; no murmur; blood pressure 116/72 mmHg
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; no masses or organ enlargement
MusculoskeletalFull range of motion; normal gait
SkinNo suspicious lesions
NeurologicalAlert and oriented; no focal deficit
PsychiatricCalm and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Cyclic vomiting syndrome, moderate to severe, meeting Rome IV criteria after a normal work-up; provisional clinical diagnosisactiveprovisional R11.15S — Synthetic provisional diagnosis at the gastroenterology consultation, anchored to his documented episodic vomiting. It is clinical, with no confirmatory test, and does not confirm any historical theory.
Recurrent episodes of nausea and vomiting over more than a year, with prodromal trembling, palpitations, and dizziness, and flatulence and fatigue between episodes; cause under evaluationresolvedconfirmed R11.2S — Synthetic presenting concern at the index visit, superseded by the provisional diagnosis at the six-week visit; the episodic vomiting is documented (D).
Common cold, without a vomiting episode; resolvedresolvedconfirmed J00S — Synthetic intercurrent illness at an unscheduled visit; chosen because infection is a common trigger of cyclic vomiting and because cold medicines interact with amitriptyline. It does not echo a documented illness.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Depression screeningCompleted todayPHQ-2 score 0; PHQ-9 also followed every three months on amitriptyline
Anxiety screeningUp to dateGAD-7 6 six weeks ago, down from 8; repeated every three months
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 2; within low-risk limits
Unhealthy drug use screeningCompleted todayNo cannabis or other drug use
Tobacco useCompleted todayDoes not smoke or vape
Blood pressure screeningCompleted today116/72 mmHg; recheck yearly from 40
Cholesterol screening and statin decisionCompleted todayTotal cholesterol 178, HDL 58, LDL 102, triglycerides 90 mg/dL; ten-year risk below 5 percent; no statin indicated
Diabetes screeningNot indicatedRecommended for adults 35 to 70 with overweight or obesity; BMI 21.7, and glucose was normal in March
HIV screeningOrderedOne-time antigen and antibody test, with his consent; no prior result on record
Hepatitis C screeningOrderedOne-time antibody test with reflex RNA, with his consent
Hepatitis B screeningOrderedOne-time triple panel (surface antigen, surface antibody, and core antibody), drawn before today's vaccine dose
Hepatitis B vaccineCompleted todayNo record of a prior series; first dose of the two-dose adjuvanted vaccine given today, second dose in one month
Influenza vaccineDueThis season's vaccine due in the autumn
COVID-19 vaccineDueDiscussed; he plans to have this season's vaccine with the influenza vaccine
TdapUp to dateBooster about seven years ago; next due in about three years
HPV vaccineNot indicatedRoutine catch-up ends at 26; at 40 with no new risk, not recommended after discussion
Colorectal cancer screeningNot indicatedStarts at 45
Prostate cancer screeningNot indicatedShared decision starts at 55
Advance care planningCompleted todayDiscussed; he will choose a health care agent and return the form

Immunizations given today: Hepatitis B vaccine (adjuvanted, two-dose series), dose 1 [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Six-month review of the cyclic vomiting plan in about seven weeks. Second hepatitis B dose in one month. HIV, hepatitis C, and hepatitis B results by portal message. Next preventive visit in one year. Next scheduled visit 1849-09-08: six-month review of response to prophylaxis. [S]

Advance Care Planning

Advance care planning was introduced as part of routine preventive care. He has no advance directive. He would like the person he lives with to speak for him if he could not, and took home the health care agent form; the agent is not named in this record. He said that what matters most is being able to keep working and to be told plainly what is known and what is not. No treatment decisions were made. [S]